Overall survival rate (%) in patients with oropharyngeal squamous cell carcinoma at 1, 3, 5, and 7 years, stratified according to p16/HPV immunohistochemistry. The gene discussed is CDKN2A; the disease is oropharynx squamous cell carcinoma.